Videos
ALung Receives CE Mark for New Hemolung XG4 Cartridge and Catheter Kits
ALung Receives CE Mark for New Hemolung XG4 Cartridge and Catheter Kits
The kits further simplify initiation of respiratory dialysis, executives claim.
10.16.15
ALung Technologies Inc. has received CE mark approval for its next generation Hemolung XG4 Cartridge and Catheter kits. The devices are used as part of the Hemolung Respiratory Assist System to provide Respiratory Dialysis, a minimally invasive extracorporeal carbon dioxide removal therapy, as an alternative or supplement to mechanical ventilation for patients suffering from acute respiratory failure.
The Hemolung XG4 Cartridge kit features a fully pre-connected circuit which makes initiating Hemolung therapy faster and safer. All tubing connections have been made in the factory, ensuring the circuit is correctly and securely assembled, and expediting the initiation of Hemolung therapy by eliminating several steps from the setup process, company executives said in a news release. Additionally, the new kits are packaged in sterile plastic trays, which are easy to handle at the bedside. In the Hemolung Catheter kit, all insertion accessories have been packaged with the catheter in one tray to improve usability under sterile conditions.
“These new kits were developed at the request of our growing user base who identified pre-connected tubing as its most desired feature,” said Peter DeComo, ALung chairman/CEO. “This update is a major step forward in making Hemolung therapy even easier to implement, and we are pleased to make it available to our customers.”
ALung's Hemolung XG4 kits currently are available in select European markets.
ALung Technologies is a privately-held Pittsburgh-based developer and manufacturer of lung assist devices. Founded in 1997 as a spin-out of the University of Pittsburgh, ALung has developed the Hemolung RAS as a dialysis-like alternative or supplement to mechanical ventilation. ALung is backed by individual investors and venture firms including Allos Ventures, Birchmere Ventures and West Capital Advisors, LLC.
Watch the video below to learn more about the Hemolung Respiratory Assist System:
The Hemolung XG4 Cartridge kit features a fully pre-connected circuit which makes initiating Hemolung therapy faster and safer. All tubing connections have been made in the factory, ensuring the circuit is correctly and securely assembled, and expediting the initiation of Hemolung therapy by eliminating several steps from the setup process, company executives said in a news release. Additionally, the new kits are packaged in sterile plastic trays, which are easy to handle at the bedside. In the Hemolung Catheter kit, all insertion accessories have been packaged with the catheter in one tray to improve usability under sterile conditions.
“These new kits were developed at the request of our growing user base who identified pre-connected tubing as its most desired feature,” said Peter DeComo, ALung chairman/CEO. “This update is a major step forward in making Hemolung therapy even easier to implement, and we are pleased to make it available to our customers.”
ALung's Hemolung XG4 kits currently are available in select European markets.
ALung Technologies is a privately-held Pittsburgh-based developer and manufacturer of lung assist devices. Founded in 1997 as a spin-out of the University of Pittsburgh, ALung has developed the Hemolung RAS as a dialysis-like alternative or supplement to mechanical ventilation. ALung is backed by individual investors and venture firms including Allos Ventures, Birchmere Ventures and West Capital Advisors, LLC.
Watch the video below to learn more about the Hemolung Respiratory Assist System:
Related Searches:
